Publication | Open Access
Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)
144
Citations
19
References
2008
Year
Metastatic Breast CancerBreast OncologyPhase Ii TrialMedicinePharmacologyWeekly NabBreast CancerPharmacotherapyTumor TargetingCancer TreatmentOncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1